Veraxa Biotech AG: VERAXA Biotech Shareholders Approve All Proposals at Extraordinary General Meeting, Strengthening Strategic Flexibility for Future Growth
ZURICH, SWITZERLAND, July 24, 2026 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (NASDAQ: VRXA; "VERAXA"), an emerging leader in the design and development of next-generation cancer therapeutics, held an Extraordinary